| Pembrolizumab-induced Stevens–Johnson syndrome in non-melanoma patients S Saw, HY Lee, QS Ng European Journal of Cancer 81, 237-239, 2017 | 108 | 2017 |
| Revisiting neoadjuvant therapy in non-small-cell lung cancer SPL Saw, BH Ong, KLM Chua, A Takano, DSW Tan The Lancet Oncology 22 (11), e501-e516, 2021 | 103 | 2021 |
| MET alterations in NSCLC—current perspectives and future challenges J Remon, LEL Hendriks, G Mountzios, R García-Campelo, SPL Saw, ... Journal of Thoracic Oncology 18 (4), 419-435, 2023 | 34 | 2023 |
| Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor–positive non–small cell lung cancer SPL Saw, S Zhou, J Chen, G Lai, MK Ang, K Chua, R Kanesvaran, QS Ng, ... JAMA Network Open 4 (11), e2131892-e2131892, 2021 | 30 | 2021 |
| Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice S Saw, J Lim, SH Lim, M Wong, C Lim, YS Yap Breast Cancer Research and Treatment 177, 197-206, 2019 | 12 | 2019 |
| Adjuvant immunotherapy in patients with early-stage non-small cell lung cancer and future directions SPL Saw, MK Ang, DSW Tan Current treatment options in oncology 23 (12), 1721-1731, 2022 | 11 | 2022 |
| Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small … AC Tan, SPL Saw, J Chen, GGY Lai, HN Oo, A Takano, DPX Lau, ... JCO Precision Oncology 6, e2200278, 2022 | 9 | 2022 |
| Practical barriers to implementation of thyroid cancer guidelines in the asia-pacific region SP Yang, LS Ying, S Saw, RM Tuttle, K Venkataraman, C Su-Ynn Endocrine Practice 21 (11), 1255-1268, 2015 | 9 | 2015 |
| PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer SPL Saw, WP Ng, S Zhou, GGY Lai, AC Tan, MK Ang, WT Lim, ... European Journal of Cancer 178, 139-149, 2023 | 7 | 2023 |
| A randomized phase 2 trial of nivolumab versus nivolumab-ipilimumab combination in EGFR-mutant NSCLC GGY Lai, JC Yeo, A Jain, S Zhou, M Pang, JJS Alvarez, NL Sim, AC Tan, ... JTO Clinical and Research Reports 3 (12), 100416, 2022 | 7 | 2022 |
| MA07. 06 circulating tumor DNA for monitoring minimal residual disease and early detection of recurrence in early stage lung cancer A Tan, G Lai, S Saw, K Chua, A Takano, B Ong, T Koh, A Jain, W Tan, ... Journal of Thoracic Oncology 16 (10), S907, 2021 | 6 | 2021 |
| Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small … AC Tan, SP Saw, GG Lai, KL Chua, A Takano, BH Ong, TP Koh, A Jain, ... Cancer Research 82 (12_Supplement), 5114-5114, 2022 | 4 | 2022 |
| Co-targeting the VEGF axis and immune checkpoints in NSCLC: back to the future SPL Saw, DSW Tan Annals of Oncology 32 (9), 1075-1076, 2021 | 2 | 2021 |
| Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage … AC Tan, GGY Lai, SPL Saw, KLM Chua, A Takano, BH Ong, TPT Koh, ... Cancer, 2024 | 1 | 2024 |
| Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges J Remon, SPL Saw, F Cortiula, PK Singh, J Menis, G Mountzios, ... Journal of Thoracic Oncology, 2023 | 1 | 2023 |
| Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic AC Tan, TJY Tan, SPL Saw, JYC Lam, YS Yap, WT Lim, DWM Tai, ... ESMO open 7 (4), 2022 | 1 | 2022 |
| OA06. 05 Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank SPL Saw, G Lai, S Zhou, J Chen, M Ang, K Chua, R Kanesvaran, QS Ng, ... Journal of Thoracic Oncology 16 (3), S114-S115, 2021 | 1 | 2021 |
| Oncogene-driven non-small cell lung cancers in patients with a history of smoking lack smoking-induced mutations CY Huang, N Jiang, M Shen, GG Lai, AC Tan, A Jain, SP Saw, MK Ang, ... Cancer Research, 2024 | | 2024 |
| New Treatment Options for Patients With Oncogene-Addicted Non–Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors SPL Saw, X Le, LEL Hendriks, J Remon American Society of Clinical Oncology Educational Book 44 (3), e432516, 2024 | | 2024 |
| Dearth of smoking-induced mutations in oncogene-driven NSCLCs despite smoking exposure CY Huang, N Jiang, M Shen, G Lai, AC Tan, A Jain, SP Saw, MK Ang, ... Cancer Research 84 (6_Supplement), 1748-1748, 2024 | | 2024 |
